EcoDrugPlus

Cyclin D1

Ensembl ID : ENSOTSG00005024040
Gene Symbol: CCND1
3 Cross references
200 Possible Orthologues:

Cyclin D1

Ensembl ID : ENSOTSG00005043621
Gene Symbol: CCND1
3 Cross references
200 Possible Orthologues:

Cyclin-Dependent Kinase 1

Ensembl ID : ENSOTSG00005027579
Gene Symbol: LOC112255192
3 Cross references
241 Possible Orthologues:

Cyclin-Dependent Kinase 1-Like

Ensembl ID : ENSOTSG00005029174
Gene Symbol: LOC112253102
3 Cross references
241 Possible Orthologues:

Cyclin-Dependent Kinase 2

Ensembl ID : ENSOTSG00005030209
Gene Symbol: CDK2
1 Cross references
196 Possible Orthologues:

Cyclin-Dependent Kinase 2-Like

Ensembl ID : ENSOTSG00005002569
Gene Symbol: LOC112216259
3 Cross references
196 Possible Orthologues:

Cyclin-Dependent Kinase 4

Ensembl ID : ENSOTSG00005002760
Gene Symbol: CDK4
1 Cross references
233 Possible Orthologues:

Cyclin-Dependent Kinase 4

Ensembl ID : ENSOTSG00005029900
Gene Symbol: CDK4
1 Cross references
233 Possible Orthologues:

Cyclin-Dependent Kinase 6

Ensembl ID : ENSOTSG00005002850
Gene Symbol: CDK6
1 Cross references
194 Possible Orthologues:

Cyclin-Dependent Kinase 6

Ensembl ID : ENSOTSG00005015574
Gene Symbol: CDK6
1 Cross references
195 Possible Orthologues:

Cyclin-Dependent Kinase 7

Ensembl ID : ENSOTSG00005003906
Gene Symbol: CDK7
1 Cross references
216 Possible Orthologues:

Cyclin-Dependent-Like Kinase 5

Ensembl ID : ENSOTSG00005022708
Gene Symbol: LOC112226799
3 Cross references
165 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).